Abstract

BackgroundAmong available digital applications (Apps), those providing personalized video exercises (PEV) may be helpful for individuals with rheumatic and musculoskeletal diseases (RMDs) undergoing functional rehabilitation [1,2,3].ObjectivesWe aimed to assess the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Effectiveness of Digital Apps Providing Personalized Exercise Videos: Systematic Review With Meta-Analysis.
Laure Gossec ... Agnès Dechartres
Journal of medical Internet research | VOL. 25
Laure Gossec, et. al.Laure Gossec ... Agnès Dechartres
13 Jul 2023
Exercise interventions on health‐related quality of life for people with cancer during active treatment
Roberta W Scherer ... Paula M Geigle
Clinical Otolaryngology | VOL. 37
Roberta W Scherer, et. al.Roberta W Scherer ... Paula M Geigle
01 Oct 2012
Exercise interventions on health-related quality of life for people with cancer during active treatment.
Paula M Geigle ... Ozlem Topaloglu
The Cochrane database of systematic reviews | VOL. 2012
Paula M Geigle, et. al.Paula M Geigle ... Ozlem Topaloglu
15 Aug 2012
Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt– a national health survey
Jorge Cerol ... Viviana Tavares
RMD Open | VOL. 2
Jorge Cerol, et. al.Jorge Cerol ... Viviana Tavares
01 Jan 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers